| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pollen | 13 | 2017 | 45 | 3.030 |
Why?
|
| Asthma | 15 | 2022 | 746 | 2.860 |
Why?
|
| Allergens | 13 | 2018 | 244 | 2.360 |
Why?
|
| Neutrophils | 7 | 2017 | 373 | 1.940 |
Why?
|
| DNA Damage | 10 | 2022 | 517 | 1.810 |
Why?
|
| Immunity, Innate | 7 | 2018 | 374 | 1.690 |
Why?
|
| Neutrophil Infiltration | 5 | 2017 | 65 | 1.660 |
Why?
|
| DNA Glycosylases | 13 | 2023 | 32 | 1.610 |
Why?
|
| Antigens, Plant | 7 | 2017 | 32 | 1.520 |
Why?
|
| Respiratory Hypersensitivity | 6 | 2016 | 52 | 1.500 |
Why?
|
| Lung | 14 | 2021 | 1484 | 1.410 |
Why?
|
| Oxidative Stress | 15 | 2022 | 804 | 1.270 |
Why?
|
| DNA Repair | 10 | 2022 | 587 | 1.270 |
Why?
|
| Rhinitis, Allergic, Seasonal | 3 | 2017 | 24 | 1.150 |
Why?
|
| Th2 Cells | 6 | 2017 | 187 | 1.140 |
Why?
|
| Respiratory Mucosa | 8 | 2018 | 91 | 1.140 |
Why?
|
| Dander | 3 | 2018 | 6 | 1.140 |
Why?
|
| Hypersensitivity | 5 | 2018 | 182 | 1.060 |
Why?
|
| Receptors, Interleukin-8B | 4 | 2018 | 15 | 1.040 |
Why?
|
| Reactive Oxygen Species | 15 | 2022 | 483 | 0.970 |
Why?
|
| Bronchoalveolar Lavage Fluid | 9 | 2017 | 158 | 0.920 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2017 | 144 | 0.900 |
Why?
|
| Plant Extracts | 6 | 2017 | 118 | 0.880 |
Why?
|
| Ambrosia | 8 | 2017 | 14 | 0.830 |
Why?
|
| NF-kappa B | 5 | 2021 | 462 | 0.810 |
Why?
|
| Guanine | 9 | 2022 | 60 | 0.740 |
Why?
|
| Pneumonia | 5 | 2018 | 327 | 0.720 |
Why?
|
| Interleukin-8 | 3 | 2017 | 209 | 0.710 |
Why?
|
| Lymphocyte Antigen 96 | 2 | 2016 | 5 | 0.650 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2018 | 9 | 0.640 |
Why?
|
| Inflammation | 11 | 2022 | 1401 | 0.630 |
Why?
|
| Cytosine | 1 | 2018 | 56 | 0.630 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 184 | 0.610 |
Why?
|
| Cytokines | 8 | 2017 | 1287 | 0.610 |
Why?
|
| Phenylurea Compounds | 1 | 2018 | 48 | 0.610 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2018 | 9 | 0.610 |
Why?
|
| Cats | 5 | 2018 | 116 | 0.590 |
Why?
|
| Animals | 40 | 2023 | 33923 | 0.580 |
Why?
|
| Blood-Air Barrier | 1 | 2017 | 4 | 0.570 |
Why?
|
| Mice, Knockout | 12 | 2018 | 3782 | 0.550 |
Why?
|
| Betacoronavirus | 1 | 2020 | 288 | 0.540 |
Why?
|
| Alternaria | 2 | 2015 | 4 | 0.530 |
Why?
|
| Peptide Hydrolases | 1 | 2017 | 141 | 0.520 |
Why?
|
| Interleukin-18 | 2 | 2015 | 60 | 0.510 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2015 | 11 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 360 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 377 | 0.470 |
Why?
|
| Forced Expiratory Volume | 1 | 2015 | 168 | 0.470 |
Why?
|
| DNA | 7 | 2022 | 1608 | 0.460 |
Why?
|
| Mice | 29 | 2022 | 17647 | 0.440 |
Why?
|
| Respiratory System | 3 | 2014 | 95 | 0.440 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 667 | 0.430 |
Why?
|
| Pandemics | 1 | 2020 | 1104 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 14 | 2017 | 1009 | 0.400 |
Why?
|
| GTP Phosphohydrolases | 2 | 2014 | 142 | 0.340 |
Why?
|
| Th1 Cells | 1 | 2009 | 152 | 0.320 |
Why?
|
| Airway Remodeling | 3 | 2018 | 20 | 0.320 |
Why?
|
| Epithelial Cells | 2 | 2014 | 907 | 0.310 |
Why?
|
| Gene Expression Profiling | 3 | 2015 | 1680 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 9 | 2018 | 4392 | 0.300 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2009 | 135 | 0.290 |
Why?
|
| Disease Models, Animal | 10 | 2018 | 4308 | 0.290 |
Why?
|
| Nitrate Reductase (NAD(P)H) | 1 | 2007 | 1 | 0.290 |
Why?
|
| Interferon-gamma | 1 | 2009 | 512 | 0.290 |
Why?
|
| Bronchitis | 1 | 2007 | 34 | 0.280 |
Why?
|
| NADPH Oxidases | 2 | 2013 | 115 | 0.270 |
Why?
|
| Nasal Mucosa | 2 | 2017 | 65 | 0.240 |
Why?
|
| Cell Differentiation | 2 | 2012 | 1936 | 0.240 |
Why?
|
| Antioxidants | 1 | 2007 | 341 | 0.230 |
Why?
|
| Humans | 28 | 2023 | 122971 | 0.220 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2014 | 207 | 0.220 |
Why?
|
| Glutathione Disulfide | 2 | 2017 | 20 | 0.210 |
Why?
|
| Mucins | 2 | 2015 | 74 | 0.200 |
Why?
|
| Ovalbumin | 2 | 2014 | 318 | 0.200 |
Why?
|
| Eosinophils | 2 | 2015 | 121 | 0.200 |
Why?
|
| Aldehyde Reductase | 2 | 2013 | 18 | 0.190 |
Why?
|
| Biomarkers | 5 | 2018 | 2952 | 0.190 |
Why?
|
| Cells, Cultured | 8 | 2015 | 3075 | 0.190 |
Why?
|
| CpG Islands | 1 | 2002 | 321 | 0.190 |
Why?
|
| Mast Cells | 2 | 2013 | 75 | 0.180 |
Why?
|
| Allergists | 1 | 2020 | 7 | 0.180 |
Why?
|
| Immunoglobulin E | 3 | 2018 | 158 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 376 | 0.180 |
Why?
|
| Cell Line | 6 | 2015 | 2787 | 0.180 |
Why?
|
| Drug Repositioning | 1 | 2020 | 22 | 0.180 |
Why?
|
| Quarantine | 1 | 2020 | 17 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 303 | 0.180 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 43 | 0.180 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 54 | 0.170 |
Why?
|
| Masks | 1 | 2020 | 39 | 0.170 |
Why?
|
| Receptors, Virus | 1 | 2020 | 104 | 0.170 |
Why?
|
| Alanine | 1 | 2020 | 181 | 0.170 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 143 | 0.160 |
Why?
|
| Interleukin-5 | 2 | 2018 | 44 | 0.160 |
Why?
|
| Signal Transduction | 7 | 2021 | 4524 | 0.160 |
Why?
|
| Chromatography, Gas | 1 | 2018 | 30 | 0.160 |
Why?
|
| Pyroglyphidae | 1 | 2018 | 9 | 0.150 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2541 | 0.150 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2018 | 83 | 0.150 |
Why?
|
| Insect Bites and Stings | 1 | 2018 | 37 | 0.150 |
Why?
|
| Genome | 2 | 2023 | 471 | 0.150 |
Why?
|
| Pulmonary Eosinophilia | 1 | 2017 | 6 | 0.150 |
Why?
|
| Rhinitis, Allergic | 1 | 2017 | 12 | 0.140 |
Why?
|
| Deoxyguanosine | 1 | 2017 | 13 | 0.140 |
Why?
|
| Receptor, PAR-2 | 1 | 2017 | 3 | 0.140 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 119 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 227 | 0.140 |
Why?
|
| Interleukin-12 | 2 | 2009 | 116 | 0.130 |
Why?
|
| Neutrophil Activation | 1 | 2016 | 16 | 0.130 |
Why?
|
| Lactoferrin | 2 | 2007 | 77 | 0.130 |
Why?
|
| Anti-Allergic Agents | 1 | 2016 | 26 | 0.130 |
Why?
|
| Inflammation Mediators | 3 | 2014 | 234 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 1086 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2016 | 118 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2020 | 736 | 0.120 |
Why?
|
| Carboxypeptidase H | 1 | 2014 | 1 | 0.120 |
Why?
|
| HEK293 Cells | 1 | 2017 | 745 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 284 | 0.120 |
Why?
|
| Mitochondria | 2 | 2009 | 684 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 658 | 0.120 |
Why?
|
| Antigens | 1 | 2014 | 156 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2833 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2009 | 874 | 0.110 |
Why?
|
| Prevalence | 1 | 2020 | 2390 | 0.110 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 156 | 0.110 |
Why?
|
| Age Factors | 1 | 2020 | 2799 | 0.110 |
Why?
|
| Oxidation-Reduction | 3 | 2015 | 444 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2015 | 757 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 279 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2014 | 68 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2014 | 178 | 0.110 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 63 | 0.110 |
Why?
|
| Cell Movement | 2 | 2021 | 838 | 0.100 |
Why?
|
| Female | 14 | 2017 | 65361 | 0.100 |
Why?
|
| Neuropeptides | 1 | 2013 | 112 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 2014 | 163 | 0.100 |
Why?
|
| Peroxides | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 83 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 2846 | 0.100 |
Why?
|
| Oxidants | 1 | 2011 | 25 | 0.100 |
Why?
|
| Autophagy | 1 | 2015 | 390 | 0.100 |
Why?
|
| Actins | 1 | 2014 | 342 | 0.100 |
Why?
|
| Necrosis | 1 | 2012 | 212 | 0.090 |
Why?
|
| ras Proteins | 1 | 2012 | 136 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 836 | 0.090 |
Why?
|
| Interleukin-4 | 2 | 2009 | 140 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 320 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2009 | 8 | 0.090 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2009 | 21 | 0.090 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 2 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1703 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2009 | 105 | 0.090 |
Why?
|
| Plant Proteins | 2 | 2007 | 75 | 0.080 |
Why?
|
| Histamine Release | 1 | 2009 | 10 | 0.080 |
Why?
|
| Chemokines | 1 | 2009 | 137 | 0.080 |
Why?
|
| Matrix Metalloproteinase 7 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Tretinoin | 1 | 2009 | 117 | 0.080 |
Why?
|
| Transcriptome | 1 | 2015 | 909 | 0.080 |
Why?
|
| Time Factors | 2 | 2016 | 6216 | 0.080 |
Why?
|
| Transcription Factors | 1 | 2018 | 2589 | 0.080 |
Why?
|
| Interleukins | 1 | 2009 | 116 | 0.080 |
Why?
|
| Serotonin | 1 | 2009 | 222 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3257 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2012 | 882 | 0.070 |
Why?
|
| Tocopherols | 1 | 2007 | 8 | 0.070 |
Why?
|
| Amaranthus | 1 | 2006 | 1 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 78 | 0.070 |
Why?
|
| Oxygenases | 1 | 2006 | 4 | 0.070 |
Why?
|
| Interleukin-13 | 1 | 2007 | 96 | 0.070 |
Why?
|
| Chloride Channels | 1 | 2007 | 62 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2007 | 74 | 0.070 |
Why?
|
| Superoxides | 1 | 2007 | 154 | 0.070 |
Why?
|
| Adult | 3 | 2017 | 28944 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 178 | 0.070 |
Why?
|
| Male | 3 | 2017 | 59957 | 0.070 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 664 | 0.060 |
Why?
|
| Aldehydes | 1 | 2005 | 28 | 0.060 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 286 | 0.060 |
Why?
|
| Epithelium | 1 | 2005 | 373 | 0.060 |
Why?
|
| Phosphorylation | 2 | 2012 | 1617 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2005 | 572 | 0.060 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2023 | 12 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2015 | 621 | 0.050 |
Why?
|
| Obesity | 1 | 2014 | 2092 | 0.050 |
Why?
|
| Cricetinae | 1 | 2023 | 411 | 0.050 |
Why?
|
| Bronchi | 3 | 2009 | 100 | 0.050 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2002 | 14 | 0.050 |
Why?
|
| Macrophages, Alveolar | 1 | 2002 | 43 | 0.050 |
Why?
|
| RNA Interference | 2 | 2014 | 497 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 132 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 164 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2002 | 77 | 0.050 |
Why?
|
| Imidazoles | 1 | 2002 | 200 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 8830 | 0.050 |
Why?
|
| Pyridines | 1 | 2002 | 222 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 773 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 582 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 771 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2002 | 291 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2012 | 702 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2002 | 646 | 0.040 |
Why?
|
| Horses | 1 | 2018 | 89 | 0.040 |
Why?
|
| Insecta | 1 | 2018 | 57 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 42 | 0.040 |
Why?
|
| Middle Aged | 1 | 2017 | 25885 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 173 | 0.040 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 629 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 217 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1021 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 48 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2009 | 811 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 3299 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 42 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2015 | 99 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 128 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2015 | 130 | 0.030 |
Why?
|
| Airway Resistance | 1 | 2014 | 36 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2014 | 4 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 144 | 0.030 |
Why?
|
| Body Fluids | 1 | 2014 | 48 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 205 | 0.030 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 68 | 0.030 |
Why?
|
| Immunity | 1 | 2015 | 183 | 0.030 |
Why?
|
| Genomic Instability | 1 | 2015 | 230 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 184 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2014 | 170 | 0.030 |
Why?
|
| Imidazolidines | 1 | 2013 | 4 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 292 | 0.030 |
Why?
|
| NADPH Oxidase 4 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2015 | 149 | 0.030 |
Why?
|
| Tryptases | 1 | 2013 | 20 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2013 | 29 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 354 | 0.030 |
Why?
|
| Vaccination | 1 | 2018 | 949 | 0.030 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2012 | 20 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 483 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 342 | 0.030 |
Why?
|
| Guanosine Diphosphate | 1 | 2012 | 13 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 2012 | 47 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1283 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2011 | 35 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 32 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 50 | 0.020 |
Why?
|
| Oxazines | 1 | 2011 | 25 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 141 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 682 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 425 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2014 | 385 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 808 | 0.020 |
Why?
|
| Glutathione | 1 | 2011 | 198 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 1170 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 865 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2009 | 10 | 0.020 |
Why?
|
| Benzophenanthridines | 1 | 2009 | 2 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2009 | 11 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1440 | 0.020 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2009 | 21 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 74 | 0.020 |
Why?
|
| Iron | 1 | 2011 | 263 | 0.020 |
Why?
|
| Exocytosis | 1 | 2009 | 64 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 637 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 263 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 151 | 0.020 |
Why?
|
| Aging | 1 | 2015 | 1175 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 339 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 2536 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 550 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 679 | 0.020 |
Why?
|
| Particle Size | 1 | 2006 | 116 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1302 | 0.020 |
Why?
|
| Proteomics | 1 | 2009 | 477 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1261 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1689 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1717 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 1006 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 4222 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2006 | 1106 | 0.010 |
Why?
|
| Chimera | 1 | 2002 | 90 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2702 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3888 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2002 | 584 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2002 | 501 | 0.010 |
Why?
|